pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,874 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT800Endpoints604BioPharma Dive231onclive165Fierce Biotech74BioSpace69raps29
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology
  • Opinion: How STAT decided to keep ‘health care’ as two words
    “‘Health care’ is such a big word for STAT. It’s a cornerstone of our coverage,” says STAT director of editorial operations Sarah Mupo.
    STAT · 1mo ago↗ source
  • STAT+: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industry
    Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
    STAT · 1mo ago↗ source
  • Health groups say HHS is trying to 'rush reinstatement' of ACIP
    A group of health organizations has accused HHS of trying to use a “self-created crisis” to “rush reinstatement” of the CDC’s frozen vaccine advisory panel. The committee and its recommendations ar…
    Endpoints · 1mo ago↗ source
← prev
page 30 of 75
next →
6
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
  • B cell therapy maker Be Bio stops hemophilia trial
    Be Biopharma disclosed in a federal clinical trials listing that it has terminated its study of a hemophilia B therapy made by editing a patient’s own cells. It was one of ...
    Endpoints · 1mo ago↗ source
  • FDA raises no major red flags with Moderna's flu shot
    The FDA provided tepid support of Moderna’s flu vaccine ahead of an advisory meeting but, more importantly, didn't appear to raise any major concerns that could hinder its prospects. In briefing do…
    Endpoints · 1mo ago↗ source
  • FDA greenlights Colorado's drug import proposal
    The FDA gave the go-ahead for Colorado to try importing cheaper drugs from Canada, but it remains to be seen how or when this would actually begin. In a letter Monday ...
    Endpoints · 1mo ago↗ source
  • STAT+: How a biotech turned a trial failure into an AI model
    In this edition of STAT Health Tech: How a biotech startup turned a failed clinical trial into an AI model, and more.
    STAT · 1mo ago↗ source
  • Lilly buys non-opioid pain drugmaker 4E
    It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.
    BioPharma Dive · 1mo ago↗ source
  • Express Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies
    Express Scripts and the PBM lobby are following in CVS Caremark’s footsteps in filing complaints challenging the FAIR Rx Act, which was passed earlier this year despite vehement opposition from PBMs.
    BioPharma Dive · 1mo ago↗ source
  • FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
    Ahead of a Thursday advisory panel meeting, agency scientists highlighted shortcomings in data accrued for a vaccine the FDA controversially refused to even review earlier this year.
    BioPharma Dive · 1mo ago↗ source
  • Edgewise to advance heart drug into Phase 3 following mid-stage data update
    Edgewise Therapeutics has shared plans to advance its drug candidate for a genetic heart disease into a registrational study on the back of updated Phase 2 data. The biotech said Tuesday ...
    Endpoints · 1mo ago↗ source
  • The U.S. infant mortality rate fell to an all-time low, though it still trails other similar nations
    Infant mortality in the U.S. dropped to a new all-time low in 2025, according to CDC data, though it still trails other similar nations.
    STAT · 1mo ago↗ source
  • How to launch a telehealth business in one day
    Want to prescribe GLP-1s online? OpenLoop Health says it can get your virtual care company up and running in as little as 24 hours. OpenLoop provides the behind-the-scenes medical group powering a…
    Endpoints · 1mo ago↗ source
  • Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill
    Plus, news about Merck, MultiValent Biotherapies, Alvotech, enGene, Mirum, and Adaptive Biotechnologies. 💸 Eli Lilly acquires another pain biotech: The Indianapolis pharma giant has made its 11th…
    Endpoints · 1mo ago↗ source
  • STAT+: ARCH-launched Neumora stops depression program
    A new AI model to improve trial enrollment, importing drugs from Canada, and more biotech news from The Readout
    STAT · 1mo ago↗ source
  • Edgewise heart drug passes key trial test
    Still, the results leave somewhat unclear how different the company’s drug is than marketed hypertrophic cardiomyopathy medicines from Bristol Myers Squibb and Cytokinetics.
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
    Weight loss drugs will be available through Medicare starting next month, thanks to a program that is supposed to be temporary but may be difficult to end
    STAT · 1mo ago↗ source
  • Neumora depression drug fails; EnGene to cut 50% of staff
    Neumora’s stumble is the latest setback for a once-promising class of brain drugs. Elsewhere, a cell therapy manufacturing specialist took steps toward an IPO and J&J made its latest U.S investment.
    BioPharma Dive · 1mo ago↗ source
  • How supplement use changed over decades
    Medicare-funded weight loss, Utah's lower drunk driving limit, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • STAT+: Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials
    As the saying goes, one man’s trash is another man’s treasure. Or as Verge Labs might put it, one company’s failed clinical trial … is that same company’s new AI…
    STAT · 1mo ago↗ source
  • UCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancer
    Glioblastoma is notoriously good at evading the immune system, making it particularly resistant to immunotherapy, but now researchers may have found a clever workaround. Scientists at the Universit…
    Endpoints · 1mo ago↗ source
  • Opinion: I’m an Alzheimer’s specialist. I still missed it in my own father
    “Alzheimer’s is not primarily a disease of old age. It is a decades-long biological process,” writes Elizabeth Bevins.
    STAT · 1mo ago↗ source
  • Opinion: Congress must reauthorize the Pandemic and All-Hazards Preparedness Act
    America’s next health emergency won’t wait for Washington, write W. Craig Vanderwagen and Jennifer B. Alton.
    STAT · 1mo ago↗ source
  • STAT+: Human Cell Atlas leader’s tie to 10x Genomics raises conflict-of-interest questions
    As the Human Cell Atlas project marks its 10th anniversary, a leader's ties to a major single-cell RNA sequencing company raise conflict-of-interest questions.
    STAT · 1mo ago↗ source
  • CMS seeks to close Medicare negotiation 'loophole'
    CMS has proposed a policy change that clarifies its stance on how products are grouped together for Medicare negotiations. Under the Inflation Reduction Act, biologics become eligible for Medicare…
    Endpoints · 1mo ago↗ source